Health Ministry asks TEP to map health issues in transmigration areas

The Union Health Ministry has issued amendments to the Drugs Rules, 1945, imposing stricter regulations on entities that submit false or fabricated data in support of their applications. In a statement released on Thursday (August 6, 2026), the Ministry explained that these amendments, in addition to the existing enforcement provisions under the Drugs and Cosmetics Act, 1940, empower licensing authorities, both at the national and state levels, to bar such entities from filing new applications for a designated period.

Previously, individuals found guilty of submitting false data faced only the rejection of their applications or the cancellation of their existing licenses. The new provisions take this a step further by implementing a temporary prohibition on future applications, which aims to discourage repeated violations. The Ministry emphasized that to ensure fairness, the amended rules require the issuance of a show-cause notice before any debarment order is granted.

Furthermore, the rules include an appellate mechanism, enabling affected entities to contest the decision if they believe it is unjust. The Ministry stated that these amendments are designed to enhance accountability among pharmaceutical applicants, deter regulatory misconduct, and ensure that drug approvals are grounded in dependable and scientifically verified evidence.